Omid Seidizadeh/LinkedIn; Sukesh Nair/eqath.org; Ian Jennings/eqath.org
May 2, 2026, 10:15
Omid Seidizadeh: Enhancing Diagnostic Strategies for von Willebrand Disease Worldwide
Omid Seidizadeh, Research Leader of the A. Bianchi Bonomi Hemophilia and Thrombosis Center, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Haemophilia, adding:
“Updated Diagnosis of von Willebrand Disease: Global Access, Genomic Insights and Quality Assurance”
Title: Updated Diagnosis of von Willebrand Disease: Global Access, Genomic Insights and Quality Assurance
Authors: Omid Seidizadeh, Sukesh Nair, Ian Jennings
Other posts featuring Omid Seidizadeh on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering